<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Chingizkhan - Latest News</title>
<link href="https://news.prfree.org/rss/chingizkhan/latest.xml"></link>
<updated>2026-07-20T23:19:29+00:00</updated>
<id>urn:uuid:16266d79-5321-3c26-4266-071dcbba63fb</id>
<entry>
<title>Immunogenicity of Biologics, Biopharmaceuticals &amp; ATMPs – Online Live Training Course</title>
<link href="https://news.prfree.org/@chingizkhan/immunogenicity-of-biologics-biopharmaceuticals-atmps-online-live-training-course-5rx6d6aei48x"></link>
<id>urn:uuid:b45bf7c4-279c-648c-4c6d-bcb8f31c4f36</id>
<summary type="html"><![CDATA[Online training (28–29 April 2026) on immunogenicity of biologics and ATMPs, covering ADA risk assessment, bioanalytical assays, and evolving EMA/FDA expectations to reduce development and regulatory risk.]]></summary>
<updated>2026-02-06T13:18:31+00:00</updated>
</entry>
<entry>
<title>Extractables &amp; Leachables Analysis online live training course on 10–12 March 2026.</title>
<link href="https://news.prfree.org/@chingizkhan/extractables-leachables-analysis-online-live-training-course-on-10-12-march-2026-9nuwyfmfm95j"></link>
<id>urn:uuid:e1541172-32ef-ceb7-86a5-aad0a36bbb12</id>
<summary type="html"><![CDATA[Regulators are tightening global expectations for extractables and leachables under draft ICH Q3E, shifting E&L to a lifecycle risk priority. Fleming’s March 2026 training helps industry apply risk-based, compliant E&L strategies.]]></summary>
<updated>2026-02-06T12:59:37+00:00</updated>
</entry>
</feed>